Fingerprint
Dive into the research topics of 'IL-17A inhibitor switching – Efficacy of ixekizumab following secukinumab failure. A single-center experience'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
IL-17A inhibitor switching – Efficacy of ixekizumab following secukinumab failure. A single-center experience
Shany Sherman, Efrat Solomon-Cohen, Iris Amitay-Laish, Emmilia Hodak, Lev Pavlovsky*
*Corresponding author for this work
Research output: Contribution to journal › Comment/debate
21
Scopus
citations